25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data

      research-article
      1 , 2 , , 1 , 3 , 4 , 5
      BMC Medical Research Methodology
      BioMed Central

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Meta-analysis handles randomized trials with no outcome events in both treatment and control arms inconsistently, including them when risk difference (RD) is the effect measure but excluding them when relative risk (RR) or odds ratio (OR) are used. This study examined the influence of such trials on pooled treatment effects.

          Methods

          Analysis with and without zero total event trials of three illustrative published meta-analyses with a range of proportions of zero total event trials, treatment effects, and heterogeneity using inverse variance weighting and random effects that incorporates between-study heterogeneity.

          Results

          Including zero total event trials in meta-analyses moves the pooled estimate of treatment effect closer to nil, decreases its confidence interval and decreases between-study heterogeneity. For RR and OR, inclusion of such trials causes small changes, even when they comprise the large majority of included trials. For RD, the changes are more substantial, and in extreme cases can eliminate a statistically significant effect estimate.

          Conclusion

          To include all relevant data regardless of effect measure chosen, reviewers should also include zero total event trials when calculating pooled estimates using OR and RR.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: not found
          • Article: not found

          Cochrane Handbook for Systematic Reviews of Interventions

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A general parametric approach to the meta-analysis of randomized clinical trials.

            Meta-analysis provides a systematic and quantitative approach to the summary of results from randomized studies. Whilst many authors have published actual meta-analyses concerning specific therapeutic questions, less has been published about comprehensive methodology. This article presents a general parametric approach, which utilizes efficient score statistics and Fisher's information, and relates this to different methods suggested by previous authors. Normally distributed, binary, ordinal and survival data are considered. Both the fixed effects and random effects model for treatments are described.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death.

              Surveys have documented the continued popularity of low-dose dopamine to influence renal dysfunction even though few data support it and editorials and reviews have discouraged its use. To evaluate the effects of low-dose dopamine (< or =5 microg/kg of body weight per minute) compared with placebo or no therapy in patients with or at risk for acute renal failure. MEDLINE (1966-January 2005), EMBASE (1980-week 5, 2005), CANCERLIT (1975-2002), CINAHL (1982-January 2005), and CENTRAL (The Cochrane Library, fourth quarter, 2004); bibliographies of retrieved publications; and additional information from 50 trials. Two reviewers independently selected parallel-group randomized and quasi-randomized controlled trials of low-dose dopamine versus control. Study methods, clinical and renal physiologic outcomes, and adverse events (arrhythmias and myocardial, limb, and cutaneous ischemia) were extracted. 61 trials that randomly assigned 3359 patients were identified. Meta-analyses using random-effects models showed no effect of low-dose dopamine on mortality (relative risk, 0.96 [95% CI, 0.78 to 1.19]), need for renal replacement therapy (relative risk, 0.93 [CI, 0.76 to 1.15]), or adverse events (relative risk, 1.13 [CI, 0.90 to 1.41]). Low-dose dopamine increased urine output by 24% (CI, 14% to 35%) on day 1. Improvements in serum creatinine level (4% relative decrease [CI, 1% to 7%]) and measured creatinine clearance (6% relative increase [CI, 1% to 11%]) on day 1 were clinically insignificant. There were no significant changes on days 2 and 3 of therapy. Statistically significant between-study heterogeneity in physiologic but not clinical outcomes was unexplained by prespecified hypotheses. Low-dose dopamine offers transient improvements in renal physiology, but no good evidence shows that it offers important clinical benefits to patients with or at risk for acute renal failure.
                Bookmark

                Author and article information

                Journal
                BMC Med Res Methodol
                BMC Medical Research Methodology
                BioMed Central (London )
                1471-2288
                2007
                23 January 2007
                : 7
                : 5
                Affiliations
                [1 ]Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada
                [2 ]Critical Care and Medicine Departments, St. Michael's Hospital, 30 Bond Street, 4Bond-015, Toronto, Ontario M5B 1W8, Canada
                [3 ]Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue Toronto, Ontario M4N 3M5, Canada
                [4 ]Department of Public Health Sciences, University of Toronto, Toronto, Canada
                [5 ]Child Health Evaluative Sciences, Hospital for Sick Children Research Institute, 123 Edward Street, Room 1206, Toronto, Ontario M5G 1E2, Canada
                Article
                1471-2288-7-5
                10.1186/1471-2288-7-5
                1783664
                17244367
                e39742be-89b4-4e41-8747-4d05843e74c6
                Copyright © 2007 Friedrich et al; licensee BioMed Central Ltd.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 14 November 2006
                : 23 January 2007
                Categories
                Research Article

                Medicine
                Medicine

                Comments

                Comment on this article